Oncology Molecular Diagnostic Market Size, Share, Trends, Growth and Forecast 2034
Oncology Molecular Diagnostic Market By Technology Type (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, and Immunohistochemistry), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Blood Cancer), By Sample Type (Tissue Samples, Blood Samples, Urine Samples, and Other Biological Samples), By End-User (Hospitals, Diagnostic Laboratories, Research Institutes, and Cancer Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 213 Report Code: ZMR-9618
Published Date: Jul-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.54 Billion | USD 7.91 Billion | 12.03% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Oncology Molecular Diagnostic Market, (2025 - 2034) (USD Billion)
- 2.2 Global Oncology Molecular Diagnostic Market : snapshot
- Chapter 3. Global Oncology Molecular Diagnostic Market - Industry Analysis
- 3.1 Oncology Molecular Diagnostic Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing cancer prevalence and the aging population
- 3.3 Market Restraints
- 3.3.1. High costs and reimbursement challenges
- 3.4 Market Opportunities
- 3.4.1. Expansion into emerging markets and developing countries
- 3.5 Market Challenges
- 3.5.1. Technical complexity and the need for a specialized workforce
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology Type
- 3.7.2 Market attractiveness analysis By Cancer Type
- 3.7.3 Market attractiveness analysis By Sample Type
- 3.7.4 Market attractiveness analysis By End User
- Chapter 4. Global Oncology Molecular Diagnostic Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Oncology Molecular Diagnostic Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Oncology Molecular Diagnostic Market - Technology Type Analysis
- 5.1 Global Oncology Molecular Diagnostic Market overview: By Technology Type
- 5.1.1 Global Oncology Molecular Diagnostic Market share, By Technology Type, 2024 and 2034
- 5.2 Polymerase Chain Reaction
- 5.2.1 Global Oncology Molecular Diagnostic Market by Polymerase Chain Reaction, 2025 - 2034 (USD Billion)
- 5.3 Next-Generation Sequencing
- 5.3.1 Global Oncology Molecular Diagnostic Market by Next-Generation Sequencing, 2025 - 2034 (USD Billion)
- 5.4 In Situ Hybridization
- 5.4.1 Global Oncology Molecular Diagnostic Market by In Situ Hybridization, 2025 - 2034 (USD Billion)
- 5.5 Immunohistochemistry
- 5.5.1 Global Oncology Molecular Diagnostic Market by Immunohistochemistry, 2025 - 2034 (USD Billion)
- 5.1 Global Oncology Molecular Diagnostic Market overview: By Technology Type
- Chapter 6. Global Oncology Molecular Diagnostic Market - Cancer Type Analysis
- 6.1 Global Oncology Molecular Diagnostic Market overview: By Cancer Type
- 6.1.1 Global Oncology Molecular Diagnostic Market share, By Cancer Type, 2024 and 2034
- 6.2 Breast Cancer
- 6.2.1 Global Oncology Molecular Diagnostic Market by Breast Cancer, 2025 - 2034 (USD Billion)
- 6.3 Lung Cancer
- 6.3.1 Global Oncology Molecular Diagnostic Market by Lung Cancer, 2025 - 2034 (USD Billion)
- 6.4 Colorectal Cancer
- 6.4.1 Global Oncology Molecular Diagnostic Market by Colorectal Cancer, 2025 - 2034 (USD Billion)
- 6.5 Prostate Cancer
- 6.5.1 Global Oncology Molecular Diagnostic Market by Prostate Cancer, 2025 - 2034 (USD Billion)
- 6.6 Blood Cancer
- 6.6.1 Global Oncology Molecular Diagnostic Market by Blood Cancer, 2025 - 2034 (USD Billion)
- 6.1 Global Oncology Molecular Diagnostic Market overview: By Cancer Type
- Chapter 7. Global Oncology Molecular Diagnostic Market - Sample Type Analysis
- 7.1 Global Oncology Molecular Diagnostic Market overview: By Sample Type
- 7.1.1 Global Oncology Molecular Diagnostic Market share, By Sample Type, 2024 and 2034
- 7.2 Tissue Samples
- 7.2.1 Global Oncology Molecular Diagnostic Market by Tissue Samples, 2025 - 2034 (USD Billion)
- 7.3 Blood Samples
- 7.3.1 Global Oncology Molecular Diagnostic Market by Blood Samples, 2025 - 2034 (USD Billion)
- 7.4 Urine Samples
- 7.4.1 Global Oncology Molecular Diagnostic Market by Urine Samples, 2025 - 2034 (USD Billion)
- 7.5 Other Biological Samples
- 7.5.1 Global Oncology Molecular Diagnostic Market by Other Biological Samples, 2025 - 2034 (USD Billion)
- 7.1 Global Oncology Molecular Diagnostic Market overview: By Sample Type
- Chapter 8. Global Oncology Molecular Diagnostic Market - End User Analysis
- 8.1 Global Oncology Molecular Diagnostic Market overview: By End User
- 8.1.1 Global Oncology Molecular Diagnostic Market share, By End User, 2024 and 2034
- 8.2 Hospitals
- 8.2.1 Global Oncology Molecular Diagnostic Market by Hospitals, 2025 - 2034 (USD Billion)
- 8.3 Diagnostic Laboratories
- 8.3.1 Global Oncology Molecular Diagnostic Market by Diagnostic Laboratories, 2025 - 2034 (USD Billion)
- 8.4 Research Institutes
- 8.4.1 Global Oncology Molecular Diagnostic Market by Research Institutes, 2025 - 2034 (USD Billion)
- 8.5 Cancer Centers
- 8.5.1 Global Oncology Molecular Diagnostic Market by Cancer Centers, 2025 - 2034 (USD Billion)
- 8.1 Global Oncology Molecular Diagnostic Market overview: By End User
- Chapter 9. Oncology Molecular Diagnostic Market - Regional Analysis
- 9.1 Global Oncology Molecular Diagnostic Market Regional Overview
- 9.2 Global Oncology Molecular Diagnostic Market Share, by Region, 2024 & 2034 (USD Billion)
- 9.3. North America
- 9.3.1 North America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.3.1.1 North America Oncology Molecular Diagnostic Market, by Country, 2025 - 2034 (USD Billion)
- 9.3.1 North America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4 North America Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034
- 9.4.1 North America Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034 (USD Billion)
- 9.5 North America Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034
- 9.5.1 North America Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034 (USD Billion)
- 9.6 North America Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034
- 9.6.1 North America Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034 (USD Billion)
- 9.7 North America Oncology Molecular Diagnostic Market, by End User, 2025 - 2034
- 9.7.1 North America Oncology Molecular Diagnostic Market, by End User, 2025 - 2034 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4.2.1 Europe Oncology Molecular Diagnostic Market, by Country, 2025 - 2034 (USD Billion)
- 9.4.2 Europe Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4 Europe Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034
- 9.4.1 Europe Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034 (USD Billion)
- 9.5 Europe Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034
- 9.5.1 Europe Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034 (USD Billion)
- 9.6 Europe Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034
- 9.6.1 Europe Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034 (USD Billion)
- 9.7 Europe Oncology Molecular Diagnostic Market, by End User, 2025 - 2034
- 9.7.1 Europe Oncology Molecular Diagnostic Market, by End User, 2025 - 2034 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.5.3.1 Asia Pacific Oncology Molecular Diagnostic Market, by Country, 2025 - 2034 (USD Billion)
- 9.5.3 Asia Pacific Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4 Asia Pacific Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034
- 9.4.1 Asia Pacific Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034 (USD Billion)
- 9.5 Asia Pacific Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034
- 9.5.1 Asia Pacific Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034 (USD Billion)
- 9.6 Asia Pacific Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034
- 9.6.1 Asia Pacific Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034 (USD Billion)
- 9.7 Asia Pacific Oncology Molecular Diagnostic Market, by End User, 2025 - 2034
- 9.7.1 Asia Pacific Oncology Molecular Diagnostic Market, by End User, 2025 - 2034 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.6.4.1 Latin America Oncology Molecular Diagnostic Market, by Country, 2025 - 2034 (USD Billion)
- 9.6.4 Latin America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4 Latin America Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034
- 9.4.1 Latin America Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034 (USD Billion)
- 9.5 Latin America Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034
- 9.5.1 Latin America Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034 (USD Billion)
- 9.6 Latin America Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034
- 9.6.1 Latin America Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034 (USD Billion)
- 9.7 Latin America Oncology Molecular Diagnostic Market, by End User, 2025 - 2034
- 9.7.1 Latin America Oncology Molecular Diagnostic Market, by End User, 2025 - 2034 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Country, 2025 - 2034 (USD Billion)
- 9.7.5 The Middle-East and Africa Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 9.4 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034
- 9.4.1 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Technology Type, 2025 - 2034 (USD Billion)
- 9.5 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034
- 9.5.1 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Cancer Type, 2025 - 2034 (USD Billion)
- 9.6 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034
- 9.6.1 The Middle-East and Africa Oncology Molecular Diagnostic Market, by Sample Type, 2025 - 2034 (USD Billion)
- 9.7 The Middle-East and Africa Oncology Molecular Diagnostic Market, by End User, 2025 - 2034
- 9.7.1 The Middle-East and Africa Oncology Molecular Diagnostic Market, by End User, 2025 - 2034 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Roche Diagnostics
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Illumina Inc.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Thermo Fisher Scientific Inc.
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Agilent Technologies Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 QIAGEN N.V.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Abbott Laboratories
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Danaher Corporation
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Bio-Rad Laboratories Inc.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 PerkinElmer Inc.
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Genomic Health Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Foundation Medicine Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Guardant Health Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Exact Sciences Corporation
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Myriad Genetics Inc.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 NeoGenomics Inc.
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Castle Biosciences Inc.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 Veracyte Inc.
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 Molecular MD Corp.
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Personal Genome Diagnostics Inc.
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 Tempus Labs Inc.
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.21 and others.
- 10.21.1 Overview
- 10.21.2 Financials
- 10.21.3 Product Portfolio
- 10.21.4 Business Strategy
- 10.21.5 Recent Developments
- 10.1 Roche Diagnostics
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Oncology Molecular Diagnostic Market attractiveness, By Technology Type
- 6. Global Oncology Molecular Diagnostic Market attractiveness, By Cancer Type
- 7. Global Oncology Molecular Diagnostic Market attractiveness, By Sample Type
- 8. Global Oncology Molecular Diagnostic Market attractiveness, By End User
- 9. Global Oncology Molecular Diagnostic Market share by Technology Type, 2025 and 2034 (USD Billion)
- 10. Global Oncology Molecular Diagnostic Market by Polymerase Chain Reaction, 2025 - 2034 (USD Billion)
- 11. Global Oncology Molecular Diagnostic Market by Next-Generation Sequencing, 2025 - 2034 (USD Billion)
- 12. Global Oncology Molecular Diagnostic Market by In Situ Hybridization, 2025 - 2034 (USD Billion)
- 13. Global Oncology Molecular Diagnostic Market by Immunohistochemistry, 2025 - 2034 (USD Billion)
- 14. Global Oncology Molecular Diagnostic Market share by Cancer Type, 2025 and 2034 (USD Billion)
- 15. Global Oncology Molecular Diagnostic Market by Breast Cancer, 2025 - 2034 (USD Billion)
- 16. Global Oncology Molecular Diagnostic Market by Lung Cancer, 2025 - 2034 (USD Billion)
- 17. Global Oncology Molecular Diagnostic Market by Colorectal Cancer, 2025 - 2034 (USD Billion)
- 18. Global Oncology Molecular Diagnostic Market by Prostate Cancer, 2025 - 2034 (USD Billion)
- 19. Global Oncology Molecular Diagnostic Market by Blood Cancer, 2025 - 2034 (USD Billion)
- 20. Global Oncology Molecular Diagnostic Market share by Sample Type, 2025 and 2034 (USD Billion)
- 21. Global Oncology Molecular Diagnostic Market by Tissue Samples, 2025 - 2034 (USD Billion)
- 22. Global Oncology Molecular Diagnostic Market by Blood Samples, 2025 - 2034 (USD Billion)
- 23. Global Oncology Molecular Diagnostic Market by Urine Samples, 2025 - 2034 (USD Billion)
- 24. Global Oncology Molecular Diagnostic Market by Other Biological Samples, 2025 - 2034 (USD Billion)
- 25. Global Oncology Molecular Diagnostic Market share by End User, 2025 and 2034 (USD Billion)
- 26. Global Oncology Molecular Diagnostic Market by Hospitals, 2025 - 2034 (USD Billion)
- 27. Global Oncology Molecular Diagnostic Market by Diagnostic Laboratories, 2025 - 2034 (USD Billion)
- 28. Global Oncology Molecular Diagnostic Market by Research Institutes, 2025 - 2034 (USD Billion)
- 29. Global Oncology Molecular Diagnostic Market by Cancer Centers, 2025 - 2034 (USD Billion)
- 30. Global Oncology Molecular Diagnostic Market share, by Region, 2025 and 2034
- 31. North America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 32. Europe Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 33. Asia Pacific Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 34. Latin America Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
- 35. The Middle-East and Africa Oncology Molecular Diagnostic Market, 2025 - 2034 (USD Billion)
Table Of Tables
- 1. Global Oncology Molecular Diagnostic Market: Snapshot
- 2. Drivers of the Oncology Molecular Diagnostic Market: impact analysis
- 3. North America Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 4. North America Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 5. North America Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 6. North America Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 7. U.S. Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 8. U.S. Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 9. U.S. Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 10. U.S. Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 11. Canada Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 12. Canada Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 13. Canada Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 14. Canada Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 15. Europe Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 16. Europe Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 17. Europe Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 18. Europe Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 19. Germany Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 20. Germany Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 21. Germany Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 22. Germany Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 23. France Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 24. France Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 25. France Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 26. France Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 27. U.K. Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 28. U.K. Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 29. U.K. Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 30. U.K. Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 31. Italy Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 32. Italy Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 33. Italy Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 34. Italy Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 35. Spain Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 36. Spain Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 37. Spain Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 38. Spain Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 39. Rest of Europe Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 40. Rest of Europe Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 41. Rest of Europe Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 42. Rest of Europe Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 43. Asia Pacific Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 44. Asia Pacific Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 45. Asia Pacific Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 46. Asia Pacific Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 47. China Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 48. China Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 49. China Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 50. China Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 51. Japan Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 52. Japan Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 53. Japan Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 54. Japan Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 55. India Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 56. India Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 57. India Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 58. India Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 59. South Korea Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 60. South Korea Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 61. South Korea Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 62. South Korea Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 63. South-East Asia Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 64. South-East Asia Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 65. South-East Asia Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 66. South-East Asia Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 67. Rest of Asia Pacific Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 68. Rest of Asia Pacific Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 69. Rest of Asia Pacific Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 70. Rest of Asia Pacific Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 71. Latin America Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 72. Latin America Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 73. Latin America Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 74. Latin America Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 75. Brazil Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 76. Brazil Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 77. Brazil Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 78. Brazil Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 79. Mexico Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 80. Mexico Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 81. Mexico Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 82. Mexico Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 83. Rest of Latin America Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 84. Rest of Latin America Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 85. Rest of Latin America Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 86. Rest of Latin America Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 87. The Middle-East and Africa Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 88. The Middle-East and Africa Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 89. The Middle-East and Africa Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 90. The Middle-East and Africa Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 91. GCC Countries Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 92. GCC Countries Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 93. GCC Countries Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 94. GCC Countries Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 95. South Africa Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 96. South Africa Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 97. South Africa Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 98. South Africa Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
- 99. Rest of Middle-East Africa Oncology Molecular Diagnostic Market revenue, By Technology Type, 2025 - 2034 (USD Billion)
- 100. Rest of Middle-East Africa Oncology Molecular Diagnostic Market revenue, By Cancer Type, 2025 - 2034 (USD Billion)
- 101. Rest of Middle-East Africa Oncology Molecular Diagnostic Market revenue, By Sample Type, 2025 - 2034 (USD Billion)
- 102. Rest of Middle-East Africa Oncology Molecular Diagnostic Market revenue, By End User, 2025 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Oncology molecular diagnostics are advanced laboratory tests that examine genetic changes, mutations, and biomarkers in cancer cells to help doctors make more informed treatment decisions for cancer patients.
The oncology molecular diagnostic market is expected to be driven by increasing cancer prevalence worldwide, advancements in precision medicine and targeted therapies, growing demand for personalized treatment options, technological improvements in genomic analysis, and expanding adoption of companion diagnostics for treatment selection.
According to our study, the global oncology molecular diagnostic market was worth around USD 2.54 billion in 2024 and is predicted to grow to around USD 7.91 billion by 2034.
The CAGR value of the oncology molecular diagnostic market is expected to be around 12.03% during 2025-2034.
The global oncology molecular diagnostic market will register the highest revenue contribution from North America during the forecast period.
Key players in the oncology molecular diagnostic market include Roche Diagnostics, Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., PerkinElmer Inc., Genomic Health Inc., Foundation Medicine Inc., Guardant Health Inc., Exact Sciences Corporation, Myriad Genetics Inc., NeoGenomics Inc., Castle Biosciences Inc., Veracyte Inc., Molecular MD Corp., Personal Genome Diagnostics Inc., and Tempus Labs Inc.
The report provides a comprehensive analysis of the oncology molecular diagnostic market, including an in-depth examination of market drivers, restraints, emerging trends, regional dynamics, and future growth prospects. It also examines the competitive dynamics, technological innovations, testing methodologies, and healthcare applications that shape the precision medicine and cancer diagnostics ecosystem.
Choose License Type
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed